Avalyn Pharma Inc. AVLN

Set alert

29.15 USD +2.48 (+9.30%)

At closeNov 6, 2026, 4:00 PM EST

29.15 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

26.13 Day range 29.18

23.33 52-week range 39.25

Held by insiders 0.00%

Held by institutions 104.09%

Float held by institutions 104.09%

Institutions 148

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	13.16%	5,835,259	169.89M	Jun 29, 2026
Novo Holdings A/S	8.76%	3,883,289	113.06M	Jun 29, 2026
SR One Capital Management, LP	7.46%	3,308,649	96.33M	Jun 29, 2026
Perceptive Advisors Llc	6.03%	2,675,296	77.89M	Jun 29, 2026
Montanova Capital LLC	5.65%	2,503,109	72.88M	Jun 29, 2026
NVP Associates, LLC	5.12%	2,268,404	66.04M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Fidelity Securities Fund-Fidelity Small Cap Growth Fund	2.78%	1,231,620	35.86M	Aug 30, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund	1.41%	627,190	18.26M	Aug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.21%	534,440	15.56M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.05%	466,565	13.58M	Sep 29, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.	0.94%	415,610	12.10M	Jun 29, 2026
T. Rowe Price Health Sciences Fund, Inc.	0.89%	396,069	11.53M	Jun 29, 2026

AVLN insiders
Insider	Relation	Latest transaction	Date	Shares held
CARROLL JILL	Director	Purchase	Apr 30, 2026	0
FMR LLC	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Apr 30, 2026	0
NOVO HOLDINGS A/S	Beneficial Owner of more than 10% of a Class of Security	Purchase	Apr 30, 2026	3,883,290
SR ONE CAPITAL MANAGEMENT, LLC	Beneficial Owner of more than 10% of a Class of Security	Purchase	Apr 30, 2026	0
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN II	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Apr 30, 2026	1,275,490

Held by funds